Your browser doesn't support javascript.
loading
[Comparing efficacy of two different hormonal therapy regimen on activity of coagulation factors VII, VIII, IX and serum lipids in menopaused women]
Iranian Journal of Diabetes and Lipid Disorders. 2004; 4 (1): 85-89
in Persian | IMEMR | ID: emr-203712
ABSTRACT

Background:

during extrinsic coagulation pathway, a complex is developed between factor VII, calcium and tissue factor [a cell membrane lipoprotein that is exposed after cell injury]. Factor VII needs calcium and vitamin K for its biologic activation. Coronary artery disease can be induced by increased level and activity of the coagulation factors VII, VIII and IX. In postmenopausal period, estrogen can decrease blood lipids and thereby decreases risk of coronary artery disease. However, the exact effects of the estrogen on the other predisposing factors of the coronary artery diseases are unknown. Our objective in this study was to evaluate the effects of oral hormone therapy regimen on fibrinogen and other coagulation factors
Search on Google
Index: IMEMR (Eastern Mediterranean) Language: Persian Journal: Iran. J. Diabetes Lipid Disord. Year: 2004

Similar

MEDLINE

...
LILACS

LIS

Search on Google
Index: IMEMR (Eastern Mediterranean) Language: Persian Journal: Iran. J. Diabetes Lipid Disord. Year: 2004